Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Public ClinicalTrials.gov record NCT04589845. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
Study identification
- NCT ID
- NCT04589845
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 920 participants
Conditions and interventions
Conditions
Interventions
- Alectinib Drug
- Atezolizumab Drug
- Belvarafenib Drug
- Camonsertib Drug
- Divarasib Drug
- Entrectinib Drug
- Inavolisib Drug
- Ipatasertib Drug
- Pralsetinib Drug
- Trastuzumab emtansine Drug
Drug
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 17, 2021
- Primary completion
- Sep 24, 2032
- Completion
- Sep 24, 2032
- Last update posted
- May 7, 2026
2021 – 2032
United States locations
- U.S. sites
- 33
- U.S. states
- 19
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Western Regional Medical Center at Cancer Treatment Centers of America | Goodyear | Arizona | 85338 | — |
| Kaiser Permanente Los Angeles | Los Angeles | California | 90027 | — |
| USC Norris Cancer Center | Los Angeles | California | 90033 | — |
| Hoag Memorial Hospital | Newport Beach | California | 92658 | — |
| UC Davis Comprehensive Cancer Center | Sacramento | California | 95817 | — |
| University Cancer & Blood Center, LLC | Athens | Georgia | 30607 | — |
| St. Alphonsus | Boise | Idaho | 83706 | — |
| Midwestern Regional Med Center | Zion | Illinois | 60099 | — |
| Horizon Oncology Research, Inc. | Lafayette | Indiana | 47905 | — |
| Maryland Hematology & Oncology. P.A. | Silver Spring | Maryland | 20904 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Metro-Minnesota Community Oncology Research Consortium | Saint Louis Park | Minnesota | 55416 | — |
| Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana | Billings | Montana | 59102 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 11101 | — |
| Montefiore Einstein Center for Cancer Care | The Bronx | New York | 10461 | — |
| Barrett Cancer Center | Cincinnati | Ohio | 45219 | — |
| Oncology Hematology Care Inc | Cincinnati | Ohio | 45242 | — |
| Consultants in Medical Oncology and Hematology | Broomall | Pennsylvania | 19008 | — |
| Alliance Cancer Specialists | Horsham | Pennsylvania | 19044 | — |
| Virginia Cancer Specialists - Leesburg | Leesburg | Pennsylvania | 20176 | — |
| Cancer Treatment Centers of America | Philadelphia | Pennsylvania | 19124 | — |
| The West Clinic | Germantown | Tennessee | 38138 | — |
| St. Jude Children'S Research Hospital | Memphis | Tennessee | 38105 | — |
| Texas Oncology - Central South | Austin | Texas | 78731 | — |
| Mary Crowley Medical Research Center | Dallas | Texas | 75230 | — |
| Texas Oncology - Baylor Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030-4009 | — |
| Texas Oncology- Northeast Texas | Tyler | Texas | 75702 | — |
| Northwest Medical Specialties, PLLC | Tacoma | Washington | 98405 | — |
| Froedtert and The Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.
Recently updated Solid Tumors trials
Other public records listing Solid Tumors. Sorted by last update posted; newest first. Not a recommendation.
- NCT07661459: Optimizing Ancillary Therapies With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI) Recruiting
- NCT07038369: A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations Active, not recruiting
- NCT03486873: Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) Recruiting
- NCT07374848: Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors Recruiting
- NCT06885281: A Study of ZL-1310 in Participants With Selected Solid Tumors Recruiting
- NCT05836324: A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04589845, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04589845 live on ClinicalTrials.gov.